Headlands Research

06/03/2026

June is Alzheimer’s & Brain Awareness Month, a time to recognize the impact of Alzheimer’s disease and other neurological conditions on individuals, families, and communities.

Alzheimer’s is a progressive disease that affects memory, thinking, and behavior, and its reach continues to grow. By raising awareness and supporting research, we move closer to a future with better outcomes for patients.

06/01/2026

We’re headed to New Orleans for the American Diabetes Association’s Scientific Sessions (June 5–8)!

From cutting-edge research to evolving standards of care, this event brings the diabetes community together like no other. Our team is excited to connect, learn, and be part of the conversations shaping what’s next in diabetes research and patient care.

Will you be attending? Schedule a time to meet up with one of our experts:

• Christopher Romero, Medical Director and Principal Investigator at Headlands Research Brownsville
• Larry Sher, Associate Medical Director and Principal Investigator at Headlands Peninsula Research Associates
• Jenine Yager Stone, Principal Investigator at Headlands Research AMCR Institute
• Josh Devine, Therapeutic Area Lead Manager - Cardiometabolic
• Tori Wallenburg, Director of Strategy & Channel Alliances

https://headlandsresearch.com/events/ada-2026-scientific-sessions/

05/29/2026

Jon Finley, MD, is a Principal Investigator at Headlands Clinical Research Atlanta (CRA) and a seasoned orthopedic specialist with more than 39 years of experience in medicine. Over the past several years at CRA, he has led and contributed to more than 40 clinical studies.

His research experience ranges from atopic dermatitis and IBS to RSV vaccines and smoking cessation. Dr. Finley’s extensive clinical background and commitment to advancing new therapies continue to support improved outcomes for patients.

05/28/2026

We’re heading to SCRS West! We're excited to join fellow sites and industry partners to talk about what’s next in site innovation, from improving trial ex*****on to enhancing the patient experience.

Reach out to schedule time with our team:

• Lauren Chazal, Chief Business Development Officer
• Ben Clark, DO, Principal Investigator at Headlands Research Scottsdale
• Jacqueline Klier, Regional Director of Operations
• Katie Houdek, Site Director at Headlands Research Scottsdale

We’d love to talk about your upcoming studies: https://headlandsresearch.com/events/scrs-west-2026/

05/28/2026

In Canada, more than 772,000 people are currently living with dementia, and that number is expected to nearly double within the next 20 years. In this episode of the (w)healthy podcast from the KGH Foundation, host Shauna Nyrose sits down with Dr. Pieter Strauss, Principal Investigator at Headlands Okanagan Clinical Trials, to explore the evolving landscape of Alzheimer's disease research and discuss the clinical trials helping shape the future of treatment.

Watch the full episode: https://www.youtube.com/watch?v=n4_KAm5M_3M

In Canada, more than 772,000 people are currently living with demen...

05/27/2026

This Mental Health Awareness Month, Headlands is encouraging open, honest conversations about mental health. When we share our experiences and listen to others, we help reduce stigma and make it easier for people to seek support.

Mental health impacts all of us, whether directly or through someone we know. Creating space for these conversations can make a meaningful difference.

If you’re comfortable, consider sharing your story. You never know who it might help.

05/26/2026

What does the future of psychedelic medicine look like, and what questions still need answers? In our latest blog post, Dr. Pieter Strauss, Principal Investigator at Headlands Okanagan Clinical Trials, and Dr. Beal Essink, Principal Investigator at Headlands Summit Research, examine the evolving regulatory landscape, emerging clinical evidence, and the complexities surrounding psychedelic therapies for conditions including treatment-resistant depression, PTSD, and substance use disorder.

From psilocybin and methylone to noribogaine, the conversation is shifting beyond scientific curiosity toward rigorous clinical evaluation, patient safety, and real-world access. Read the blog post: https://headlandsresearch.com/blogs/the-evolution-of-psychedelic-medicine-regulatory-changes-and-clinical-promise/

05/25/2026

Headlands is heading to the American Diabetes Association’s Scientific Sessions, June 5–8, in New Orleans. We’re looking forward to engaging with the community, exploring the latest advancements, and continuing conversations that move diabetes research forward.

If you’ll be there, schedule a time to connect with one of our experts:

• Christopher Romero, Medical Director and Principal Investigator at Headlands Research Brownsville
• Larry Sher, Associate Medical Director and Principal Investigator at Headlands Peninsula Research Associates
• Jenine Yager Stone, Principal Investigator at Headlands Research AMCR Institute
• Josh Devine, Therapeutic Area Lead Manager - Cardiometabolic
• Tori Wallenburg, Director of Strategy & Channel Alliances

https://headlandsresearch.com/events/ada-2026-scientific-sessions/

05/22/2026

Headlands Research is looking forward to attending SCRS West! As a network of dedicated research sites, we’re committed to advancing site excellence, operational innovation, and stronger collaboration across the clinical trial ecosystem.

If you'll be there, schedule a time to connect with our team to explore how we can support your next study:

• Lauren Chazal, Chief Business Development Officer
• Ben Clark, DO, Principal Investigator at Headlands Research Scottsdale
• Jacqueline Klier, Regional Director of Operations
• Katie Houdek, Site Director at Headlands Research Scottsdale

https://headlandsresearch.com/events/scrs-west-2026/